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A 47-year-old man had recurrent, episodic swelling of the right upper eyelid for about 2 years. There was
a progressively enlarging, palpable mass over the superotemporal region of the right orbit without
tenderness, local heat, or erythema. Ophthalmic examination revealed proptosis and ptosis of the right
eye without vision decrease or ocular motility disturbance. An orbital computed tomography scan
showed a huge lacrimal gland causing inferior displacement of the globe with proptosis. An anterior
orbitotomy was done, and the pathological analysis revealed marked lymphoplasma cell inﬁltration with
mild to moderate ﬁbrosis surrounding the lobules of the lacrimal glands. No lymphoepithelial islands
were seen. Immunohistochemically, about 40e50% of the immunoglobulin G (IgG)-positive cells were
IgG4 positive, and the ratio of serum IgG4 to total IgG was 80.9%, compatible with a diagnosis of IgG4-
related chronic sclerosing dacryoadenitis. IgG4-related chronic sclerosing dacryoadenitis may be a sign of
Mikulicz disease, an IgG4-related systemic disease. Determination of the serum IgG4 concentration and
IgG4/IgG ratio is necessary for clinical diagnosis. Long-term follow-up is also mandatory because of the
possible complication of lymphoma.
Copyright  2011, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC.
All rights reserved.1. Introduction
Many orbital diseases can invade the lacrimal gland. In adults,
infection, inﬂammation, and benign and malignant epithelial
tumors can occur in the lacrimal gland fossa [1]. Clinical symptoms
and signs combined with a pattern of neuroimaging abnormalities
on computed tomography or magnetic resonance imaging are often
very helpful in reaching the correct diagnosis. Those who present
with a unilateral lacrimal gland mass without signs of inﬂamma-
tion may need surgical biopsy for deﬁnite diagnosis.
2. Case report
A 47-year-old man hadmultiple episodes of swelling of the right
upper eyelid for about 2 years. There was a progressively enlarging,
non-tender mass over the superotemporal region of the right orbit.
His best corrected visual acuity was 20/20 in both eyes. Prop-
tosis and ptosis were noted in the right eye, and no ocular motilityalmology, National Taiwan
aipei, Taiwan. Tel.: þ886 2
Jou).
ddhist Compassion Relief Tzu Chidisturbance was found. Orbital computed tomography without
enhancement showed a prominent lacrimal gland with displace-
ment of the globe and proptosis in the right eye (Fig. 1).
We performed an anterior orbitotomy, and the pathological
results revealed the inﬁltration of heavy lymphoid cells with
prominent germinal center formation. The lobular architecture of
the lacrimal gland was still preserved, and there was marked
inﬁltration of lymphoplasma cells with mild to moderate ﬁbrosis
surrounding the lobules of the lacrimal glands. No lymphoepi-
thelial islands were seen (Figs. 2A and 2B). An immunohisto-
chemical stain showed that the lymphocytes were polyclonal and
composed of T cells (positive for CD3) and B cells (positive for
CD20) (Figs. 2C and 2D). Immunoglobulin G4 (IgG4)-positive cells
accounted for about 40e50% of the total IgG-positive cells (Figs.
2E and 2F). IgG4-related chronic sclerosing dacryoadenitis was
impressed. The serum level of IgG was 1570 mg/dL (reference
range, 1419.63 279.84 mg/dL) and IgG4 was 1270 mg/dL
(reference range, 3e201 mg/dL). The ratio of serum IgG4 to IgG
(reference range, 3e6%) was 80.9%. Serum protein electropho-
resis showed polyclonal gammopathy. IgG4-related chronic
sclerosing dacryoadenitis was diagnosed, and long-term follow-
up was advised because of the possible complication of
lymphoma.Foundation. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. (A) Axial view on orbital computed tomography (CT) showing a prominent right
lacrimal gland (white arrow). (B) Coronal view on the orbital CT also shows gland
enlargement (black arrow).
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Chronic dacryoadenitis represents any lacrimal gland inﬂam-
mation in which there is hypertrophy and enlargement of the
gland [2]. It usually develops insidiously, and as a general rule,
causes no pain. Chronic dacryoadenitis is usually caused by
inﬂammatory disorders, including idiopathic orbital inﬂammation,
sarcoidosis, thyroid ophthalmopathy, Sjogren’s syndrome, and
benign lymphoepithelial lesions; it may also be caused by syphilis
and tuberculosis. Neoplastic lesions may simulate chronic
dacryoadenitis and must be considered in the differential diag-
nosis. Although the clinical diagnosis of chronic dacryoadenitis is
relatively easy to establish, the actual etiology may be more
difﬁcult to identify; in many instances, it is necessary to biopsy the
gland to verify the diagnosis [2]. Treatment can then be directed
toward the underlying condition. We report a proven case of IgG4-
related chronic sclerosing dacryoadenitis. Its presentation was
similar to, but did not fully satisfy, the criteria of Mikulicz disease
(MD).
MD is characterized by idiopathic, bilateral, painless,
symmetrical swelling of the lacrimal and salivary glands. It was
ﬁrst reported in 1888 by Johann vonMikuliczeRadecki [3] and has
been considered a part of primary Sjogren’s syndrome (SS)
because of its similarity with the pathological ﬁndings in Morgan
and Castleman’s report in 1953 [4]. However, this concept has
been changed by recent studies; Tsubota et al. [5] reported that
lacrimal gland acinar cells in cases with MD maintained their
function and were not programmed for cell death, and sicca
syndrome was not observed in MD patients. Yamamoto et al. [6,7]
disclosed that MD had few autoimmune reactions and good
responsiveness to glucocorticoids, leading to the recovery of the
gland function. In their view, MD represented an IgG4-related
systemic disease that differed substantially from SS. The histo-
pathological features of IgG4-related sclerosing diseases are
dense lymphoplasmacytic inﬁltration intermixed with ﬁbrosis,
obliterative phlebitis, and prominent inﬁltration of IgG4-positiveplasma cells [8]. By comparison, few IgG4-positive cells were seen
in the tissues of patients with typical SS [7,9]. IgG4 is the rarest
subclass of IgG in healthy subjects. Serologically, IgG4 is elevated
in patients with IgG4-related diseases; in these patients, rheu-
matoid factor and antinuclear, anti-SS-A/Ro, and anti-SS-B/La
antibodies are signiﬁcantly lower than those in patients with
typical SS [9].
It is still controversial whether a unilateral lesion of the
lacrimal glands or swelling of the lacrimal glands alone without
the involvement of the salivary glands eventually progresses to
MD. Yamamoto et al. [7] experienced a case of bilateral
involvement of only the lacrimal glands. They had the impres-
sion that some of the pathogenic features diagnosed in Küttner’s
tumor (chronic sclerosing sialadenitis) or chronic dacryadenitis
are the same as those in MD. Cheuk et al. [10] reported six cases
of IgG4-related chronic sclerosing dacryoadenitis, one of which
involved a unilateral lacrimal gland and two of which involved
the bilateral lacrimal glands without the swelling of the salivary
glands.
Nowadays, MD is recognized as one of the new clinical entities
[6,9,11]dthe IgG4-related systemic disease (IgG4-positive mul-
tiorgan lymphoproliferative syndrome [9])dwhich involves one
or more of the exocrine or extranodal sites with lympho-
plasmacytic inﬁltrates and sclerosis, accompanied by an elevated
IgG4 titer in the serum. Mutiple diseases have been reported,
including autoimmune pancreatitis; sclerosing cholangitis;
Kuttner’s tumor; inﬂammatory pseudotumor of the lung, liver,
and breast; retroperitoneal and mediastinal ﬁbrosis; interstitial
nephritis; autoimmune hypophysitis; and many other inﬂam-
matory conditions [9,11]. Dense inﬁltration of IgG4-positive
plasma cells and elevated levels of serum IgG4 in these cases
suggest that IgG4 plays a major role in the pathogenesis.
However, the etiology and mechanism of development of IgG4-
positive cells are still unknown. In Zen et al.’s [12] study, T helper
2 and regulatory immune reactions were upregulated in the
affected tissues in cases of autoimmune pancreato-cholangitis
and related disorders. Akitake et al.’s [13] study suggested the
involvement of excessive T helper 2 responses to intestinal
microﬂora in the development of IgG4-related sclerosing disease.
In Kamisawa and Okamoto’s [11] view, given the preponderance
of the disease among elderly men and the marked, dramatic
response to oral steroid therapy, the pathogenesis of autoim-
mune pancreatitis may not involve an autoimmune mechanism
but might be caused by other mechanisms, such as an allergic
reaction.
MD is mainly treated by the administration of steroids [7].
This leads to rapid improvement in glandular swelling as well as
in lacrimal and salivary secretions. Glucocorticoid administration
has also been shown to improve hypergammaglobulinemia [7].
According to Takahira et al.’s [8] experience, when steroid
treatment was undesirable, excision of enlarged lacrimal glands
(occasionally bilateral) was an alternative treatment for MD.
Cheuk et al. [14] reported three cases of ocular adnexal
lymphoma arising in IgG4-related chronic sclerosing dacryoade-
nitis. One case was high-grade follicular lymphoma and the other
two cases were extranodal marginal zone B-cell lymphoma of the
mucosa-associated lymphoid tissue type. In their series, the
frequency was 10% among 30 cases of IgG4-related chronic scle-
rosing dacryoadenitis, but this ﬁguremay have been overestimated.
However, the association with malignant lymphoma is an impor-
tant issue in the clinical management of these patients. Therefore,
long-term follow-up is essential in patients with IgG4-related
chronic sclerosing dacryoadenitis for early detection of lymphoma
transformation.
Fig. 2. Histopathological pictures of the lacrimal gland mass. Hematoxylin and eosin stain with low magniﬁcation (A, magniﬁcation 40) and high magniﬁcation (B, magniﬁcation
400) showing heavy lymphoid inﬁltration with prominent germinal center formation. The lobular architecture of the lacrimal gland is still preserved. Moreover, there is marked
inﬁltration of lymphoplasma cells (green arrows in B indicate plasma cells) with mild to moderate ﬁbrosis surrounding the lobules of the lacrimal glands. Immunohistochemical
staining using anti-CD3 antibody (C: magniﬁcation, 100) and anti-CD20 antibody (D: magniﬁcation, 100) reveals that the lymphocytes are polyclonal and composed of T cells
(positive for CD3) and B cells (positive for CD20). Immunohistochemical staining using anti-IgG antibody (E: magniﬁcation, 200) and anti-IgG4 antibody (F: magniﬁcation, 200)
showing IgG-positive cells and IgG4-positive cells. IgG¼ immunoglobulin G; IgG4¼ immunoglobulin G4.
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